Prevention

Higher rates of self-reported drug use exist among the HIV-positive population, highlighting the need for interventions in at-risk populations.

Researchers at the Weizmann Institute of Science have discovered that phages are able to communicate with each other in order to coordinate how to best approach the infection process.

University of Washington researchers have discovered that telomeres are shorter in adults who had experienced more diarrheal infections as infants.

The new pediatric vaccine formulation for diphtheria, tetanus, pertussis, and poliomyelitis (DTaP) may solve the issue of vaccine schedule adherence.

Centers for Disease Control and Prevention officials are reporting epidemic flu levels across the United States, along with three new pediatric deaths from the virus.

The FDA has released a Consumer Update that warns individuals that improper use of nasal rinsing devices, such as neti pots, can actually increase risk of infection.

The Los Angeles County Department of Public Health has concluded that the measles outbreak in California has been limited to those who are unvaccinated.

The rise of the mcr-1 gene highlights the hurdles against the bigger fight that is antimicrobial resistance

The Joint United Nations Programme on HIV/AIDS and medical technology industry partners have announced new efforts to better diagnose bacterial infections at the recent World Economic Forum Annual Meeting in Davos, Switzerland.

Cancer specialists at the UT Southwestern Medical Center are reminding women to continue going for Pap smears even if they have received the human papillomavirus (HPV) vaccine.

Through environmental cleaning and student-oriented education, Humber College in Toronto, Canada, has managed to quell a nasty outbreak of norovirus.

The National Institute of Allergy and Infectious Diseases (NIAID) plans to fund research projects designed to discover and develop new antibiotics to treat these troublesome bacteria.

While we look to emerging infectious disease outbreaks and the threat of biological weapons, it's easy to forget the responsibilities of our domestic research.

A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).

With flu season underway, a pair of recent studies highlight the impact of winter weather on influenza activity and raise questions about the right time to receive a flu shot.

New research from Pew Charitable Trusts has found that quality issues are not the only factor that contribute to drug shortages.

Researchers from the Julius Center for Health Sciences and Primary Care at the University Medical Center in Utrecht, The Netherlands, examine the cost-effectiveness of the most commonly used treatments for community-acquired pneumonia.

This article is the second part of two-part coverage on a study conducted by Rutgers University researchers that analyzes the effects of misdiagnosing fungal infections on the increasing rates of antimicrobial resistance.

A recent study conducted by Rutgers University researchers analyzes the effects of misdiagnosing fungal infections on the increasing rates of antimicrobial resistance.

Stanford University researchers investigating potential use of wearable fitness trackers in healthcare find that the devices can be an important tool in the early detection of illness.

UCLA researchers have developed an online risk assessment calculator that will allow individuals to check their “PrEP score.”

Their commentary effectively represents a position statement for the ASTMH, with the leaders/authors pledging to continue working with political leaders and “global health stakeholders in support of evidence-based policies and programs” designed to ensure public health in the United States and abroad.

The researchers discovered that the protein is responsible for immune response and destruction of the bacteria.

An additional nine states are reporting widespread influenza activity, in what is already a busy flu season that has been marked by severe illness caused by the influenza A (H3N2) strain.

Insurance companies are denying members coverage to expensive drugs, like Harvoni, and those infected with HCV are filing lawsuits.